Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03899506 · ClinicalTrials.gov registry record
Olanzapine Versus Midazolam for Agitation
A clinical trial, sponsored by Hennepin Healthcare Research Institute.
- Terminated
- Registry status
- 206
- Enrollment target
NCT03899506 is a clinical trial that was terminated before completion, run by Hennepin Healthcare Research Institute. The registered enrollment target is 206 participants.
The verdict
NCT03899506 was terminated before completion, sponsored by Hennepin Healthcare Research Institute.
- TERMINATED
- Registry status
- 206 participants
- Enrollment target
Study Summary
The goal of this research investigation is to conduct a prospective observation of the comparative efficacy of midazolam versus olanzapine for the treatment of acute undifferentiated agitation in the emergency department.
Interventions
- DRUG Midazolam
- DRUG Olanzapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2018-06-18 |
| Est. Completion | 2018-07-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03899506
The ClinicalTrials.gov registry entry for NCT03899506 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam is the first listed.
NCT03899506 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03899506 about?
NCT03899506 is a clinical study titled "Olanzapine Versus Midazolam for Agitation". The goal of this research investigation is to conduct a prospective observation of the comparative efficacy of midazolam versus olanzapine for the treatment of acute undifferentiated agitation in the emergency department.
What is the current status of trial NCT03899506?
This trial is currently terminated. The enrollment target is 206 participants. The study started on 2018-06-18. Estimated completion is 2018-07-16.
What interventions are being tested in trial NCT03899506?
The interventions under investigation include: Midazolam (DRUG), Olanzapine (DRUG).
Who is sponsoring clinical trial NCT03899506?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.